GS Investments’s Boston Scientific BSX Stock Holding History

GS Investments’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$838K	Buy	19,625 +9,850	+101%	+$535K	0.61%	56
2026 Q1	$613K	Buy	+9,775	New	+$782K	0.35%	60

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GS Investments's BSX Position: Q2 2026 in Review

GS Investments increased its Boston Scientific (BSX) stake by 101% in Q2 2026, buying an estimated $535K and bringing the position to 19,625 shares worth $838K. The position accounts for 0.61% of the portfolio, ranked #56.

GS Investments first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. 1,478 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

GS Investments held 19,625 shares of Boston Scientific worth $838K as of Q2 2026.
GS Investments bought 9,850 Boston Scientific shares in Q2 2026, an estimated $535K.
Boston Scientific made up 0.61% of GS Investments's portfolio in Q2 2026, its #56 holding.
GS Investments first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
1,478 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on GS Investments's 13F filing for Q2 2026, filed 6 Aug 2026.